The RESET System Pivotal Clinical Trial (Protocol Revision K)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 264 participants.
Also called NCT04101669
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 264 participants
- Sponsor
- Morphic Medical Inc.
- Registry
-
NCT04101669
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT04101669. Randomized; triple masking; primary purpose treatment. Start 2019-09-09 (actual); primary completion 2027-12-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The RESET System Pivotal Clinical Trial (Protocol Revision K)
- Acronym
- STEP-1
- Condition
- Diabetes type2
- Condition
- Obesity
- Intervention (Device)
- RESET Liner
- Intervention (Other)
- Sham
- Lead sponsor
- Morphic Medical Inc.
- Collaborator
- Biostatistical Consulting, Inc.
Record details
- Record id
cardio:ct-nct04101669- Content hash
4b5c3be76fa645f73c30733bdd75f691a0c01d69369466d67ec56c6a020eb8d4